Lincoln Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 1,406.12 million compared to INR 1,274.68 million a year ago. Revenue was INR 1,463.34 million compared to INR 1,309.28 million a year ago. Net income was INR 237.13 million compared to INR 230.27 million a year ago. Basic earnings per share from continuing operations was INR 11.84 compared to INR 11.5 a year ago. Diluted earnings per share from continuing operations was INR 11.84 compared to INR 11.5 a year ago.
For the six months, sales was INR 2,640.83 million compared to INR 2,496.56 million a year ago. Revenue was INR 2,762.99 million compared to INR 2,551.28 million a year ago. Net income was INR 387.25 million compared to INR 407.29 million a year ago. Basic earnings per share from continuing operations was INR 19.33 compared to INR 20.33 a year ago. Diluted earnings per share from continuing operations was INR 19.33 compared to INR 20.33 a year ago.